Eleven organizations representing health care providers, including the AHA, April 29 urged the Centers for Medicare & Medicaid Services not to hold accountable care organizations responsible for anomalous Medicare spending beyond their control, such as aberrant catheter spending, noting significantly higher spending in 2023 for two catheter codes billed by durable medical equipment suppliers. The Institute for Accountable Care analyzed Medicare claims for those codes from the CMS Virtual Research Data Center and discovered a nearly 20-fold increase over two years — from $153 million in 2021 to $3.1 billion in 2023 — with almost all of the increase attributed to just 10 DME suppliers. The group asks CMS to remove questionable claims from ACO financial calculations, create an outlier policy to account for other forms of anomalous spending, and provide ACOs an option for a second reconciliation.  
  
"We strongly urge CMS to address these policies for the Medicare Shared Savings Program (MSSP), in the upcoming Medicare Physician Fee Schedule proposed rule, and the ACO Realizing Equity, Access, and Community Health (REACH) Model, which doesn’t need formal rulemaking," the letter notes. "We also request that CMS continue to work with stakeholders on long-term solutions to address suspected and confirmed fraud." 

Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…